Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization
|
|
- Baldwin Oliver
- 5 years ago
- Views:
Transcription
1
2 Louise Brown born First IVF baby Born to Lesley Brown, bilateral tubal blockage Natural cycle, single egg fertilization
3 IVF first reported attempts at IVF IVF births in rabbits in USA first human IVF (Edwards, Bavister) Birth of first IVF baby (Steptoe, Edwards) Birth of first baby after ICSI (intracytoplasmic sperm injection) (Palermo)
4 ICSI Metaphase II oocyte
5 Pronuclear stage hrs 2PN 24 hrs later, ET 8 hrs later
6 Short term consequences oocyte damage embryo transfer similar to IVF no increased morphological abnormality
7 IVF 32,958 treatment cycles conducted 5953 babies were born in Australia more than half the cycles use microinjection/icsi
8
9 Higher order multiples clearly associated with adverse neonatal outcomes Twins still 1:5 of pregnancies from ART (compared to 1:80 spontaneously)
10 Increased preterm birth, LBW, perinatal mortality, cerebral palsy Absolute risk much greater than singleton
11 1:6 will be a miscarriage 1:14 will be premature 1:30 will have a birth defect 1:100 will die at or around the time of birth 1:400 will have cerebral palsy 1:14,000 will have imprinting disorder
12 Increased risk after ART from 1/14 to 1/7 RR 2 present for singleton gestation?iatrogenic?underlying pathologies e.g. fibroids (Helmerhorst et al, BMJ 2004;328:261)
13 Increased risk of VLBW (<1500g) RR3 ( ) Increased risk of LBW (<2500g) RR 1.4 ( ) (Helmhorst et al, BMJ, 2004;328:261)
14 RR 1.68 ( )
15 Karyotypic abnormalities Y chromosome deletions Imprinting disorders
16 Sex chromosomal abnormalities After ICSI Risk from 1: in spontaneous conception to 1:100 after ICSI (not IVF) Chorionic villus sampling or amniocentesis offered routinely in Belgium to couples pregnant after ICSI.
17 4% of males with severe male factor infertility have deletions of Y chromosome(daz and RBM) Male offspring generated by ICSI have the same defect (Page et al, Human Reproduction, 1999)(presumably the same manifestation)
18 1:14,000 pregnancies spontaneously conceived have imprinting disorders which predispose to brain abnormalities, tumours e.g. Prader Willi, Beckwith Weidemann, Angelman syndomes.
19 From One allele from a parent is selectively inactivated increased after ART to 1:4000
20 Hansen et al, HumReprod 2005
21 RR 1.3 Background 3% After ART 4% No difference between IVF and ICSI
22 Barker hypothesis - patterns of adult disease associated with low birth weight rather than socio-economic status and other risk factors
23 Dutch famine of 1945 Longitudinal study of adults exposed to maternal starvation whilst in utero at varying gestations 1st trimester - obesity, AS, CAD 2nd trimester - IGTT, COPD 3rd trimester - insulin resistance, IGTT other disease e.g. breast cancer, SZ, cognitive function T Roseboom 2000
24 Does embryo exposure to in vitro culture conditions change programming for fetal and adult life? If so, how? What is the strength of this selective force?
25 Will this be part of our medical history of the future? Birth weight Twinning, triplets ART
26 Spontaneous M/C 1:6 Prem 1:14 Cong abn 1:30 PNM 1:100 Sex chrom abn 1:300 Imprinting disorder 1:14000 After ART M/C?1:4 Prem 1:7 Cong abn 1:25 PNM 1:99 Sex chrom abn 1:100 Imprinting disorder 1:4000
27 More than 90% of children born following ART are healthy and normal ART is increasingly used allowing couples to achieve pregnancies not otherwise achievable. Long term data on the health of ART children are lacking.
28 Appropriate timing of ART Adequate counselling of couples Careful selection of treatments and couples with appropriate workup Optimization of spontaneous conception
29 Reduction of multiple pregnancies = healthy families for Australia BESST - birth emphasising a successful singleton at term
30 Transvaginal oocyte collection Preparation Technique Complications Embryo transfer transcervical Preparation Technique Complications
31 Standard of care Ultrasound guidance
32 Aspiration of follicles Flushing with double lumen needle or no flushing with single lumen buffered solution or media
33 Infection 1/5000, reduced by half with antibiotic Particularly with endometiomata, hydrosalpinges?increased with PID Injury to other structures Blood vessel Bowel
34
35 Appropriate timing Full bladder with anteverted uterus
36 Ultrasound control Avoid fundal contact Aim for upper to middle third of uterus
37 ??Infection OHSS if pregnant
38 Prevention of Ovarian Hyperstimulation Syndrome
39 1. To counsel couples on the best protocol for assisted reproduction for their individual case 2. To counsel couples undertaking assisted reproduction of their success rate 3. To appropriately conduct and supervise protocols of assisted reproductive technologies 4. To reduce the occurrence of ovarian hyperstimulation syndrome 5. To treat women with ovarian hyperstimulation syndrome
40
41 Mandatory to have written precycle information on OHSS Mandatory to have protocols to reduce the risk of OHSS Mandatory to have clear information on what to do if symptoms develop ie written information on emergency care Mandatory to report all cases requiring admission to Qld Health
42 How can we get our patients to understand the importance of preventing this condition?
43 Preventable condition Difficult to treat once it is established Caused by the stimulation of too many eggs on the PLUS ovaries by FSH LH activity (or HCG) Takes about a week to develop to full extent after LH/HCG given Always a well patient when you are making the decisions to prevent OHSS
44 A medical condition characterized by ovarian enlargement and fluid accumulation with peritoneal, pleural and (rarely) pericardial cavities following treatment with ovarian stimulating drugs, most typically FSH containing preparations. The action of LH or hcg is required to develop the syndrome.
45 PCOS and OHSS
46 What are the symptoms and signs?
47 Clinical consequences are predominantly related to intravascular fluid depletion and include: hypotension haemoconcentration oliguria, renal impairment, hepato-renal syndrome pulmonary thromboembolism respiratory distress Key symptoms are nausea, SOB, abdominal pain and distension. Vomiting is always severe OHSS UPO
48 By what mechanism do these young woman die?
49 1/30,000 = mortality usually die of thromboembolic complications - stroke, PTE, occasionally complications of treatment such as heparin induced thrombocytopenia, also ovarian bleeding
50 How many eggs are enough to give a couple a realistic chance of pregnancy without a significant risk of OHSS?
51 Can get severe OHSS with as few as 13 oocytes in woman, particularly those with risk factors
52 Firstly those you might identify at the time of planning an IVF/ICSI cycle
53 young age low body weight history of OHSS PCO RR 2.46 compared with non-pcos (Delvigne and Rozenberg 2002) PCOS High dose of FSH
54 Formal baseline USS in all patients to pick up PCO Diagnose PCOS Consider metformin particularly if past history of OHSS/cycle cancellation Low dose FSH Warn about variable ovarian response Early scan at 7-8 days to detect hyperstimulatory response
55 iatrogenic ovarian stimulation 2 types early onset: related to hcg trigger / flare late onset: related to ensuing pregnancy spontaneous FSH receptor mutations
Dr Manuela Toledo - Procedures in ART -
Dr Manuela Toledo - Procedures in ART - Fertility Specialist MBBS FRANZCOG MMed CREI Specialities: IVF & infertility Fertility preservation Consulting Locations East Melbourne Planning a pregnancy - Folic
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.
*40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print
More informationLaboratoires Genevirer Menotrophin IU 1.8.2
Important missing information VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Infertility is when a woman cannot get pregnant (conceive) despite having regular unprotected sexual
More informationWOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER
*40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility
More informationEuropean IVF Monitoring (EIM) Year: 2013
European IVF Monitoring (EIM) Year: 2013 Name of the country Poland Name and full address of the contact person. Anna Janicka, PhD Polish Society of Reproductive Medicine and Embryology Fertility and Sterility
More informationEuropean IVF Monitoring (EIM) Year: 2012
European IVF Monitoring (EIM) Year: 2012 Name of the country Poland Name and full address of the contact person. Professor Rafal Kurzawa, MD PhD Wojska Polskiego 103 Street 70-483 Szczecin Poland Telephone
More informationPatient Overview: Invitro Fertilisation
Patient Overview: Overview IVF stands for in-vitro fertilisation i.e. literally fertilisation in a glass dish. You may also hear the term ART used which stands for Assisted Reproductive Technologies. IVF
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationCore Safety Profile. Pharmaceutical form(s)/strength: Lyophilised powder for injection / 75 IU. Date of FAR:
Core Safety Profile Active substance: Urofollitropin Pharmaceutical form(s)/strength: Lyophilised powder for injection / 75 IU P - RMS: UK/H/PSUR/0059/001 Date of FAR: 04.12.2009 4.2 Posology and method
More informationOverview. In Vitro Fertilization: a Success Story
Does IVF cause adverse perinatal outcomes? Paolo Rinaudo *, MD PhD Rebecca A. Jackson %, MD Departments of Ob/Gyn & *Center for Reproductive Sciences & % Epi/Biostats University of California, San Francisco
More informationInfertility. Thomas Lloyd and Samera Dean
Infertility Thomas Lloyd and Samera Dean Infertility Definition Causes Referral criteria Assisted reproductive techniques Complications Ethics What is infertility? Woman Reproductive age Has not conceived
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationIVF Patient Information
What is IVF? IVF (In Vitro Fertilisation) is a treatment by which fertilisation of eggs by sperm takes place outside the body in a dish in an IVF laboratory. An ovary has a pool of immature eggs. In a
More informationInformation and Risks Associated with In Vitro Fertilization
1 of 14 INTRODUCTION The following information offers a description for potential adverse effects and risks of In Vitro Fertilization (IVF) offered at the Regional Fertility Program. Our staff will educate
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationIn Vitro Fertilization, Intracytoplasmic Sperm Injection Assisted Hatching Embryo Freezing
NAME (Patient): NAME (Partner): DOB: DOB: MEDICAL RECORD NUMBER: MEDICAL RECORD NUMBER: Informed Consent for Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection Assisted Hatching
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationBrighton & Hove CCG PLS CONFERENCE Dr Carole Gilling-Smith Medical Director
Brighton & Hove CCG PLS CONFERENCE 2016 Dr Carole Gilling-Smith Medical Director FERTILITY CHALLENGES IN THE NHS A TERTIARY CARE PERSPECTIVE LEARNING OBJECTIVES Understand the pathways through assisted
More informationFIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Société Suisse de Médecine de la Reproduction
SGRM / SSMR Schweizerische Gesellschaft für Reproduktionsmedizin FIVNAT-CH Schweizerische Gesellschaft für Reproduktionsmedizin Annual report 2013 Cycles 2012 Version 15.06.2014 Date of analysis 02.12.2013
More informationInformation Booklet. Exploring the causes of infertility and treatment options.
Information Booklet Exploring the causes of infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Faith is taking the first step even if you don t see the whole
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationThis Booklet is provided by The New Hope Center for Reproductive Medicine. TSPoe
This Booklet is provided by The New Hope Center for Reproductive Medicine TSPoe Page 1 of 20 Booklet-ART Procedures Jan-2017 Assisted Reproductive Techniques: In Vitro Fertilization, Intracytoplasmic Sperm
More information1. NAME OF THE MEDICINAL PRODUCT. Gonapeptyl 0.1 mg/1 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1. NAME OF THE MEDICINAL PRODUCT Gonapeptyl 0.1 mg/1 ml solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe of 1 ml solution for injection contains 100 micrograms
More informationH. Christina Lee, M.D., J.D., H.C.L.D., F.A.C.O.G. 95 Highland Avenue, #100 Telephone (610) Bethlehem, PA Fax (610)
Overview CONSENT TO TREATMENT WITH ASSISTED REPRODUCTIVE TECHNOLOGIES Assisted reproductive technology (ART) The Centers for Disease Control and Prevention (CDC) defines ART to include "all fertility treatments
More informationCounseling for Potential Clients of RT Services
Assisted Reproductive Technology Unit Department of Obstetrics and Gynaecology The Chinese University of Hong Kong The Prince of Wales Hospital Counseling for Potential Clients of RT Services Husband s
More informationPartner Name: Patient Signature Partner Signature (If applicable) Date (COS/IUI) Witness Name Witness Signature Date
1. Please place your initials below to indicate which components of controlled ovarian Stimulation (COS) and intrauterine insemination (IUI) treatment you agree to undertake in your upcoming treatment
More informationInitials: Patient: Partner (if applicable): 5 Columbus Circle New York, NY (646)
In Vitro Fertilization Intracytoplasmic Sperm Injection Assisted Hatching Embryo Freezing Please place your initials below to indicate which components of IVF treatment you agree to undertake in your upcoming
More informationInformed Consent for Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, Embryo Cryopreservation
Page 1 of 24 Informed Consent for ART, Seth Levrant MD PC, Partners in Reproductive Health, version may2013 Informed Consent for Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection,
More informationInformed Consent for Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection (ICSI), Assisted Hatching, and Embryo Freezing
Patient: Print Name Partner: Account #: Print Name Informed Consent for Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection (ICSI), Assisted Hatching, and Embryo Freezing OVERVIEW
More informationCommittee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler
Committee Paper Committee: Scientific and Clinical Advances Advisory Committee Meeting Date: 12 May 2009 Agenda Item: 4 Paper Number: SCAAC(05/09)01 Paper Title: ICSI guidance Author: Hannah Darby and
More informationINTRACYTOPLASMIC SPERM INJECTION
1 Background... 2 2 Male Factor Infertility... 2 3 ICSI... 3 4 Surgical sperm aspiration... 4 5 What is the chance of success?... 6 6 What are the risks?... 7 M Rajkhowa, October 2004 Authorised by V Kay
More informationInformed Consent for Assisted Reproduction: In Vitro Fertilization,
Informed Consent for Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, Sperm and Embryo Cryopreservation Please place your initials below to acknowledge
More informationSouth Jersey Fertility Center (SJFC) Informed Consent for Assisted Reproduction: In Vitro Fertilization and Embryo Freezing
South Jersey Fertility Center (SJFC) Informed Consent for Assisted Reproduction: In Vitro Fertilization and Embryo Freezing Please sign your name(s) below to indicate which components of IVF treatment
More informationUniversal Embryo Cryopreservation: Frozen versus Fresh Transfer. Zaher Merhi, M.D.
Universal Embryo Cryopreservation: Frozen versus Fresh Transfer Zaher Merhi, M.D. Disclosure: None Fewer complications with IVF 1.5% children in US are born through ART 1.1 million children since 2006
More informationJAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019
JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019 Page 1 Table of Contents Executive Summary... 3 About this Guidance... 4 Glossary:... 5 ART
More informationCONSENT TO TREATMENT WITH ASSISTED REPRODUCTIVE TECHNOLOGIES
Overview Assisted reproductive technology (ART) The Centers for Disease Control and Prevention (CDC) defines ART to include "all fertility treatments in which both eggs and sperm are handled. In general,
More informationEvaluation of the Infertile Couple
Overview and Definition Infertility is defined as the inability of a couple to fall pregnant after one year of unprotected intercourse. Infertility is a very common condition as in any given year about
More informationInfertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary
Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that
More informationUW MEDICINE PATIENT EDUCATION. In Vitro Fertilization How to prepare and what to expect DRAFT
UW MEDICINE PATIENT EDUCATION In Vitro Fertilization How to prepare and what to expect This handout tells how to prepare for and what to expect when you go through a cycle of in vitro fertilization. It
More informationFertility care for women diagnosed with cancer
Saint Mary s Hospital Department of Reproductive Medicine Information for Patients Fertility care for women diagnosed with cancer Contents Page Overview... 2 Our service... 2 Effects of cancer treatment
More informationIVF Treatment Plan & Consents
Seth Levrant MD PC, Partners in Reproductive Health. www.myivfbaby.com Page 1 of 24 IVF Treatment Plan & Consents Patient name: Date: Spouse / partner name: for IVF when? Provider of Eggs (oocytes) and
More informationTHE CENTER FOR HUMAN REPRODUCTION (CHR)
PATIENT NAME: RECORD #: THE CENTER FOR HUMAN REPRODUCTION (CHR) 21 East 69 th Street, New York, NY 10021 T: 212-994-4400; F: 212-994-4499 Informed Consent for Assisted Reproduction: In Vitro Fertilization,
More informationInfertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations
Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationInfertility F REQUENTLY A SKED Q UESTIONS. Q: Is infertility a common problem?
Infertility (female factors). In another one third of cases, infertility is due to the man (male factors). The remaining cases are caused by a mixture of male and female factors or by unknown factors.
More informationM Magdy EL-Sheikh FRCOG London, FRCS Glasgow Director ART unit Dr Soliman Fakeeh hospital Jeddah Saudi Arabia
M Magdy EL-Sheikh FRCOG London, FRCS Glasgow Director ART unit Dr Soliman Fakeeh hospital Jeddah Saudi Arabia The versatile nature reproduction Reproduction as a sign of life Reproduction as a sign of
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationCONSENT FORM FOR A COUPLE USING A GESTATIONAL CARRIER
CONSENT FORM FOR A COUPLE USING A GESTATIONAL CARRIER INSTRUCTIONS: This consent form provides a description of the treatment that you are undertaking. Read the consent completely. If you have any questions
More informationPRETREATMENT ASSESSMENT & MANAGEMENT (MODULE 1 B) March, 2018
PRETREATMENT ASSESSMENT & MANAGEMENT (MODULE 1 B) March, 2018 Clinical Assessment A thorough clinical evaluation is a prerequisite for ART A thorough clinical evaluation as detailed in the female and male
More informationPreimplantation Genetic Diagnosis (PGD) in Western Australia
Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationIn Vitro Fertilization Process, Risk, and Consent
Department of Obstetrics and Gynecology Strong Fertility Center Kathleen Hoeger, MD, MPH Director Bala Bhagavath, MD Vivian Lewis, MD John T. Queenan, Jr., MD Wendy Vitek, MD In Vitro Fertilization Process,
More informationCONSENT TO TREATMENT WITH ASSISTED REPRODUCTIVE TECHNOLOGIES
Overview Assisted reproductive technology (ART) The Centers for Disease Control and Prevention (CDC) defines ART to include "all fertility treatments in which eggs or embryos are handled. In general, ART
More informationFact Sheet. Quick guide to infertility and treatment options
Fact Sheet Quick guide to infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Ovarian Hyper stimulation syndrome OHSS is a potentially life threatening complication
More informationFertility Treatment: Do not be Distracted
Fertility Treatment: Do not be Distracted Fertility Treatment: do not be distracted by worthless recommendation Fertility Treatment: Do not be Distracted When contemplating options for fertility treatment
More informationIntroduction to Intrauterine Insemination (IUI) Service
Introduction to Intrauterine Insemination (IUI) Service Assisted Reproductive Technology Unit The Chinese University of Hong Kong Prince of Wales Hospital 2017 Treatment Procedures IUI involves six main
More informationInformed Consent for ART
Informed Consent for Assisted Reproduction: Oocyte Recipient, In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, Embryo Cryopreservation Please place your initials below to indicate
More informationGENA2. Source Booklet. General Studies (Specification A) General Certificate of Education Advanced Subsidiary Examination June 2011
General Certificate of Education Advanced Subsidiary Examination June 2011 General Studies (Specification A) GENA2 Unit 2 AS Science and Society Source Booklet Source for use with Questions 1.1 to 1.30.
More informationPatient Information: Patient Name: Date of Birth:
Weill Cornell Medicine Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Informed Consent for Oocyte (Egg) Cryopreservation Patient Information: Part 1: I have requested to be treated
More informationGPVTS TEACHING APRIL 2016 FERTILITY
GPVTS TEACHING APRIL 2016 FERTILITY Djavid Alleemudder - Consultant Obstetrics & Gynaecology DEFINITIONS What is the definition of infertility? Failure to conceive after 12 months despite regular, unprotected
More informationIn Vitro Fertilization What to expect
Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,
More informationThrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology
Thrombosis during assisted reproduction Scott Nelson Muirhead Chair in Obstetrics & Gynaecology ART can be as safe as natural pregnancy!! What used to be the risk of thrombosis in ART!! We can use AMH
More informationTreating Infertility
Treating Infertility WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 About 10% of couples in the United States are infertile. Infertility is a condition in which a woman has not been able
More informationBiology of fertility control. Higher Human Biology
Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting
More informationCauses of Infertility and Treatment Options
Causes of Infertility and Treatment Options Dr Mrs.Kiran D. Sekhar Former vice President-FOGSI Former Chairperson- Genetics and Foetal medicine-fogsi Founder and Medical Director-Kiran Infertility centre
More informationGenetics Review and Reproductive Options in Kennedy Disease
+ Alice Schindler, MS, CGC Genetic Counselor, NIH/NINDS/Neurogenetics Branch Heather Montie, PhD, Assistant Professor Department of Bio-Medical Sciences Philadelphia College of Osteopathic Medicine Annual
More informationEgg Freezing. Information for Patients and Partners. Date of Issue:28/08/15 Doc 327 Issue 08 1 of 11 Approved by Jane Blower
Egg Freezing Information for Patients and Partners Date of Issue:28/08/15 Doc 327 Issue 08 1 of 11 What is this service and who is it for? This treatment is for two groups of patients. You may be about
More informationA mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort
Chapter 6 A mild strategy in IVF results in favourable outcomes in terms of term live birth, cost and patient discomfort Heijnen E.M., Eijkemans M.J., De Klerk C., Polinder S., Beckers N.G., Klinkert E.R.,
More informationSupplemental figure 1. Adjusted odds ratios for gestational diabetes, pre-eclampsia, premature birth and miscarriage for women with and without PCOS.
Supplemental figure 1 Adjusted odds ratios for gestational diabetes, pre-eclampsia, premature birth and miscarriage for women with and without PCOS. * Denominator is all pregnancies, adjusted for age,
More informationGetting Help for Obstructive Azoospermia A BASIC GUIDE TO MALE. A doctor s guide for patients developed by the American Urological Association, Inc.
A BASIC GUIDE TO MALE Getting Help for Obstructive Azoospermia A doctor s guide for patients developed by the American Urological Association, Inc. Based on the AUA Best Practice Policy and ASRM Practice
More informationClinical Policy Committee
Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments
More informationThe Jones Institute for Reproductive Medicine Founded on Science, Dedicated to Life
The Jones Institute for Reproductive Medicine Founded on Science, Dedicated to Life Assisted reproductive technologies: State-of-the-ART Sergio Oehninger, MD, PhD Professor and Vice-Chair, Dept. Ob/Gyn
More informationGONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch])
PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch]) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all
More informationTop 10 questions in fertility
Top 10 questions in fertility Mr Rehan Salim MD MRCOG Head of Reproductive Medicine Consultant Gynaecologist & Subspecialist in Reproductive Medicine Imperial College NHS Trust Learning objectives Patient
More informationIn Vitro Fertilization
Patient Education In Vitro Fertilization About the treatment This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this
More informationSupplementary Online Content
Supplementary Online Content Sandin S, Nygren K-G, Iliadou A, Hultman C, Reichenberg. Autism and Mental Retardation Among Offspring Born After In Vitro Fertilization. JAMA. doi:10.1001/jama.2013.7222.
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Elonva 100 micrograms solution for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pre-filled syringe contains
More informationGONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch])
GONAL-f PEN Recombinant human follicle stimulating hormone (follitropin alfa [rch]) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about GONALf. It does
More informationMinimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology
Minimising IVF related mortality and morbidity Scott Nelson Muirhead Professor in Obstetrics & Gynaecology We rarely say no - so what I will cover today VTE as an example of a modifiable IVF complication
More informationELONVA Corifollitropin alfa (rch)
ELONVA Corifollitropin alfa (rch) NAME OF THE DRUG Corifollitropin alfa solution for injection Corifollitropin alfa, a gonadotrophin designed as a sustained follicle stimulant is a glycoprotein consisting
More informationPresident : Indian Society for Assisted Reproduction (ISAR) Past President FOGSI. Past Chairman ICOG. Founder Trustee Women s Empowerment Foundation
Founder President: The PCOS Society, India Honorary Fellow of the Royal College of Obst.& Gyn. Prof.Duru Shah President : Indian Society for Assisted Reproduction (ISAR) Past President FOGSI. Past Chairman
More informationPrinciples of Ovarian Stimulation
Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle
More informationELONVA Corifollitropin alfa (rch) Consumer Medicine Information
ELONVA Corifollitropin alfa (rch) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ELONVA. It does not contain all the available information. It does
More informationOocyte Cryopreservation Process, Risk, and Consent
Oocyte Cryopreservation Process, Risk, and Consent While embryos and sperm have been frozen and thawed with good results for many years, eggs have proved much more difficult to manage. Newer egg freezing
More informationFINAL PAPER COVER PAGE
FINAL PAPER COVER PAGE Research Question: Most couples desire to have children at some point during the course of their relationship. However, infertility is an important problem that many couples face.
More informationDr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management
Dr Guy Gudex Director Repromed 17:00-17:30 Recent Advances in Fertility Management Recent Advances in Fertility Management Practice Nurses Programme NZMA GP CME June 2018 Dr Guy Gudex ART in NZ -2014 ACART
More informationGONAL-f (follitropin alfa [rch]) solution for injection
(follitropin alfa [rch]) solution for injection Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information.
More informationFollitropin alfa (rch)/lutropin alfa (rch) Powder for Injection. This leaflet answers some common questions about PERGOVERIS.
PERGOVERIS 150 IU / 75 IU Follitropin alfa (rch)/lutropin alfa (rch) Powder for Injection Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PERGOVERIS.
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationClinical Policy Committee
Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year
More informationHonorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.
Prof.Duru Shah Founder President The PCOS Society (India) President Elect of the Indian Society for Assisted Reproduction (ISAR) Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive
More informationNICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic
NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in
More informationA new set of consent documents is required for each IVF attempt. CRM staff is available to answer your questions related to the consent documents.
Informed Consent Packet - In Vitro Fertilization (IVF) This packet contains the required IVF treatment consent documents. Please read, consider and, if you agree, sign and return the attached documents.
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Elonva 100 micrograms solution for injection Elonva 150 micrograms solution for injection corifollitropin alfa Read all of this leaflet carefully before you start
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Bemfola 75 IU/0.125 ml solution for injection in a pre-filled pen Bemfola 150 IU/0.25 ml solution for injection in a pre-filled pen Bemfola 225 IU/0.375 ml solution
More informationUTERINE LEIOMYOSARCOMA. About Uterine leiomyosarcoma
UTERINE LEIOMYOSARCOMA Uterine Lms, Ulms Or Just Lms Rare uterine malignant tumour that arises from the smooth muscular part of the uterine wall. Diagnosis Female About Uterine leiomyosarcoma Uterine LMS
More informationReproductive Technology, Genetic Testing, and Gene Therapy
Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples
More informationNaProTechnology. An Integrated Approach to Infertility. Tracy Parnell. Geneva 2005
NaProTechnology An Integrated Approach to Infertility Tracy Parnell Geneva 2005 Outline Scientific foundations Illustrative case history Research Discussion and questions NPT Natural Procreative Technology(NPT)
More information